US 11291672
Betamethasone oral spray formulation and method of use to treat ataxia
granted A61KA61K31/573A61K47/02
Quick answer
US patent 11291672 (Betamethasone oral spray formulation and method of use to treat ataxia) held by GRACE THERAPEUTICS INC. expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GRACE THERAPEUTICS INC.
- Grant date
- Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/573, A61K47/02, A61K47/12, A61K47/26